Mutations of RB1 and TP53 genes could be potential predisposing factors, with inactivation of these tumor suppressor genes found in the initial NSCLC as well as in SCLC at progression, as was found in de novo SCLC [117,118]. Here, TP53 is linked to non-small cell lung carcinoma.